article · Microbes and Infectious Diseases /Microbes and Infectious Diseases
Background: HBV genotypes are associated with differences in the severity of underlying liver disease and genes mutation. Being the commonest HBV genotype in Egypt we studied the characteristics of HBV genotype D regarding the clinical presentations, gene mutations and fibrosis status. Methods: 100 chronic HBV genotype D patients studying the baseline characteristics, hepatic fibrosis, BCP, pre-core gene mutation and HBeAg status. Results: 76% of the patients were under 40 years. ALT and AST were within normal ranges in 63% and 71% respectively and HBV PCR > 20000 IU/ML in 65%. Advanced fibrosis (> F2) was present only in 11% associated with older age (>40years), elevated ALT and AST, viral load (p value = 0.038, 0.014, <0.001 and 0.006 respectively). 62% of patients were HBeAg negative disease, pre-core mutation was detected in 62 patients, 17 patients with BCP mutation and 10 patients carried both pre-core and BCP mutations. No relation detected between the viral load (p = 0.630), progression of fibrosis (p= 0.52) and HBeAg status. No relation with the viral load and serum transaminases and the BCP gene mutations. Conclusion: HBV genotype D is associated with HBV chronic inactive state rather than acute hepatitis and active infection. Advanced fibrosis is less observed in genotype D patients increasing with age and associated with elevated enzymes and high viral load. HBeAg negative disease is highly expressed and pre-core mutation more observed than BCP mutation. No relation between the progression of fibrosis, viral load and HBeAg expression and BCP gene mutation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/mid.2025.362629.2564
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.